{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T20:40:09Z","timestamp":1751920809066,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,7]]},"DOI":"10.7759\/cureus.87463","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T20:09:07Z","timestamp":1751918947000},"source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Pathological Relevance of N-acylsphingosine Amidohydrolase 2 (ASAH2) and Related Proteins in Alzheimer\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Abdalla","family":"Khabazeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunju","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Ekuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jetish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Poursahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gewei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Towia","family":"Libermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volney","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2014.10.001","article-title":"In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseases","volume":"73","author":"F\u00e9ger J","year":"2015","unstructured":"F\u00e9ger J, Hirsch EC. In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseases. Annales Pharmaceutiques Fran\u00e7aises. 2015, 73:3-12. 10.1016\/j.pharma.2014.10.001","journal-title":"Annales Pharmaceutiques Fran\u00e7aises"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2014.10.034","article-title":"Biomarkers in the diagnosis and management of Alzheimer's disease","volume":"64","author":"Wurtman R","year":"2015","unstructured":"Wurtman R. Biomarkers in the diagnosis and management of Alzheimer's disease. Metabolism. 2015, 64:47-50.","journal-title":"Metabolism"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000179","article-title":"Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments","volume":"28","author":"Zetterberg H","year":"2015","unstructured":"Zetterberg H. Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments. Curr Opin Psychiatry. 2015, 28:402-9. 10.1097\/YCO.0000000000000179","journal-title":"Curr Opin Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3233\/jad-140816","article-title":"Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review","volume":"43","author":"Chiam JT","year":"2015","unstructured":"Chiam JT, Dobson RJ, Kiddle SJ, Sattlecker M. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review. J Alzheimers Dis. 2015, 43:303-14. 10.3233\/jad-140816","journal-title":"J Alzheimers Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212261","article-title":"SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients","volume":"14","author":"Begic E","year":"2019","unstructured":"Begic E, Hadzidedic S, Kulaglic A, Ramic-Brkic B, Begic Z, Causevic M. SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients. PLoS One. 2019, 14:0212261. 10.1371\/journal.pone.0212261","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3233\/jad-130380","article-title":"Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study","volume":"38","author":"Kiddle SJ","year":"2014","unstructured":"Kiddle SJ, Sattlecker M, Proitsi P, et al.. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis. 2014, 38:515-31. 10.3233\/jad-130380","journal-title":"J Alzheimers Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.78","article-title":"Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes","volume":"5","author":"Kiddle SJ","year":"2015","unstructured":"Kiddle SJ, Steves CJ, Mehta M, et al.. Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes. Transl Psychiatry. 2015, 5:e584. 10.1038\/tp.2015.78","journal-title":"Transl Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3233\/jad-140669","article-title":"Longitudinal protein changes in blood plasma associated with the rate of cognitive decline in Alzheimer\u2019s disease","volume":"49","author":"Sattlecker M","year":"2015","unstructured":"Sattlecker M, Khondoker M, Proitsi P, et al.. Longitudinal protein changes in blood plasma associated with the rate of cognitive decline in Alzheimer\u2019s disease. J Alzheimers Dis. 2015, 49:1105-14. 10.3233\/jad-140669","journal-title":"J Alzheimers Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement","volume":"10","author":"Sattlecker M","year":"2014","unstructured":"Sattlecker M, Kiddle SJ, Newhouse S, et al.. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. Alzheimer's & Dementia. 2014, 10:724-34. 10.1016\/j.jalz.2013.09.016","journal-title":"Alzheimer's & Dementia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.06.4951","article-title":"Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay","volume":"15","author":"Shi L","year":"2019","unstructured":"Shi L, Westwood S, Baird AL, et al.. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimers Dement. 2019, 15:1478-88. 10.1016\/j.jalz.2019.06.4951","journal-title":"Alzheimers Dement"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3233\/jad-150020","article-title":"Blood protein markers of neocortical amyloid-\u03b2 burden: a candidate study using SOMAscan technology","volume":"46","author":"Voyle N","year":"2015","unstructured":"Voyle N, Baker D, Burnham SC, et al.. Blood protein markers of neocortical amyloid-\u03b2 burden: a candidate study using SOMAscan technology. J Alzheimers Dis. 2015, 46:947-61. 10.3233\/jad-150020","journal-title":"J Alzheimers Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0258-6","article-title":"The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology","volume":"9","author":"Westwood S","year":"2017","unstructured":"Westwood S, Liu B, Baird AL, et al.. The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology. Alzheimers Res Ther. 2017, 9:31. 10.1186\/s13195-017-0258-6","journal-title":"Alzheimers Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3056","article-title":"Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease","volume":"14","author":"Nicolas G","year":"2018","unstructured":"Nicolas G, Acu\u00f1a-Hidalgo R, Keogh MJ, et al.. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease. Alzheimers Dement. 2018, 14:1632-9. 10.1016\/j.jalz.2018.06.3056","journal-title":"Alzheimers Dement"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman RA","year":"2024","unstructured":"Rissman RA, Langford O, Raman R, et al.. Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. Alzheimers Dement. 2024, 20:1214-24. 10.1002\/alz.13542","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081334","article-title":"Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates","volume":"8","author":"Ruiz A","year":"2013","unstructured":"Ruiz A, Pesini P, Espinosa A, et al.. Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates. PLoS One. 2013, 8:81334. 10.1371\/journal.pone.0081334","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-007-0081-5","article-title":"A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease","volume":"8","author":"Avramopoulos D","year":"2007","unstructured":"Avramopoulos D, Wang R, Valle D, Fallin MD, Bassett SS. A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. Neurogenetics. 2007, 8:111-20. 10.1007\/s10048-007-0081-5","journal-title":"Neurogenetics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102233200","article-title":"Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney","volume":"276","author":"Mitsutake S","year":"2001","unstructured":"Mitsutake S, Tani M, Okino N, et al.. Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem. 2001, 276:26249-59. 10.1074\/jbc.M102233200","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.03.009","article-title":"Purification and characterization of human intestinal neutral ceramidase","volume":"89","author":"Ohlsson L","year":"2007","unstructured":"Ohlsson L, Palmberg C, Duan RD, Olsson M, Bergman T, Nilsson A. Purification and characterization of human intestinal neutral ceramidase. Biochimie. 2007, 89:950-60. 10.1016\/j.biochi.2007.03.009","journal-title":"Biochimie"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105898","article-title":"Reelin protects against pathological \u03b1-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease","volume":"175","author":"Cho E","year":"2022","unstructured":"Cho E, Kim K, Kim H, Cho SR. Reelin protects against pathological \u03b1-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease. Neurobiol Dis. 2022, 175:105898. 10.1016\/j.nbd.2022.105898","journal-title":"Neurobiol Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.7978","article-title":"Association of altered liver enzymes with Alzheimer's disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers","volume":"3","author":"Nho K","year":"2019","unstructured":"Nho K, Kueider-Paisley A, Ahmad S, et al.. Association of altered liver enzymes with Alzheimer's disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open. 2019, 3:197978. 10.1001\/jamanetworkopen.2019.7978","journal-title":"JAMA Netw Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121573","article-title":"Role of ceramidases in sphingolipid metabolism and human diseases","volume":"8","author":"Parveen F","year":"2019","unstructured":"Parveen F, Bender D, Law SH, et al.. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019, 8:1573. 10.3390\/cells8121573","journal-title":"Cells"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(01)02878-2","article-title":"Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells","volume":"506","author":"Romiti E","year":"2001","unstructured":"Romiti E, Meacci E, Tanzi G, et al.. Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells. FEBS Lett. 2001, 506:163-8. 10.1016\/s0014-5793(01)02878-2","journal-title":"FEBS Lett"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.13","article-title":"Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP)","volume":"3","author":"Reitz C","year":"2013","unstructured":"Reitz C, Tosto G, Vardarajan B, et al.. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl Psychiatry. 2013, 3:e256. 10.1038\/tp.2013.13","journal-title":"Transl Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00576-2","article-title":"Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease","volume":"17","author":"Salasova A","year":"2022","unstructured":"Salasova A, Monti G, Andersen OM, Nykjaer A. Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease. Mol Neurodegener. 2022, 17:74. 10.1186\/s13024-022-00576-2","journal-title":"Mol Neurodegener"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207932200","article-title":"O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein","volume":"278","author":"Tani M","year":"2003","unstructured":"Tani M, Iida H, Ito M. O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein. J Biol Chem. 2003, 278:10523-30. 10.1074\/jbc.M207932200","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3370","article-title":"Neutral\/alkaline and acid ceramidase activities are actively released by murine endothelial cells","volume":"275","author":"Romiti E","year":"2000","unstructured":"Romiti E, Meacci E, Tani M, et al.. Neutral\/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem Biophys Res Commun. 2000, 275:746-51. 10.1006\/bbrc.2000.3370","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002522200","article-title":"Molecular cloning and characterization of a human mitochondrial ceramidase","volume":"275","author":"El Bawab S","year":"2000","unstructured":"El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, Hannun YA. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem. 2000, 275:21508-13. 10.1074\/jbc.M002522200","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1242\/dev.139295","article-title":"Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway","volume":"143","author":"Lian G","year":"2016","unstructured":"Lian G, Dettenhofer M, Lu J, et al.. Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. Development. 2016, 143:4509-20. 10.1242\/dev.139295","journal-title":"Development"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhy073","article-title":"Formin 2 regulates lysosomal degradation of Wnt-associated \u03b2-catenin in neural progenitors","volume":"29","author":"Lian G","year":"2019","unstructured":"Lian G, Chenn A, Ekuta V, et al.. Formin 2 regulates lysosomal degradation of Wnt-associated \u03b2-catenin in neural progenitors. Cereb Cortex. 2019, 29:1938-52. 10.1093\/cercor\/bhy073","journal-title":"Cereb Cortex"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl EJ","year":"2015","unstructured":"Goetzl EJ, Boxer A, Schwartz JB, et al.. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015, 85:40-7. 10.1212\/wnl.0000000000001702","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367194-investigating-the-pathological-relevance-of-n-acylsphingosine-amidohydrolase-2-asah2-and-related-proteins-in-alzheimers-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T20:09:08Z","timestamp":1751918948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367194-investigating-the-pathological-relevance-of-n-acylsphingosine-amidohydrolase-2-asah2-and-related-proteins-in-alzheimers-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.87463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}